心脈醫療(688016.SH):分支型主動脈覆膜支架系統獲得醫療器械註冊證
格隆匯3月17日丨心脈醫療(688016.SH)公佈,公司獲得國家藥品監督管理局頒發的關於分支型主動脈覆膜支架系統的醫療器械註冊證,Cratos®分支型主動脈覆膜支架系統是基於 Castor®分支型主動脈覆膜支架及輸送系統推出的新一代升級產品,在產品性能和手術操作體驗方面均取得了顯著提升,在傳承 Castor®分支型支架的一體化分支結構和近端無裸段設計的基礎上,進一步優化了輸送系統,帶來了更優的臨牀應用表現。該產品的海外市場推廣同步推進中,已於 2024 年獲得歐盟定製證書,併成功在多國開展臨牀應用。該產品醫療器械註冊證的獲得,進一步鞏固了公司在主動脈領域的技術領先優勢,進而提高公司在主動脈及外周血管介入市場的整體競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.